
Benzinga Pro data, Aquestive Therapeutics (NASDAQ:AQST) reported Q4 sales of $11.08 million. Earnings fell to a loss of $28.95 million, resulting in a 98.87% decrease from last quarter. In Q3, Aquestive Therapeutics brought in $13.29 million in sales but lost $14.55 million in earnings.